JWH-167
Code | Size | Price |
---|
TAR-T32337-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T32337-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T32337-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
JWH 167, a synthetic cannabinoid (CB), has moderate affinities for central CB1 (Ki = 90 nM) and peripheral CB2 (Ki = 159 nM) receptors. Its physiological and toxicological properties have not been evaluated. This product is only applied for forensic and research purposes.
CAS:
864445-37-4
Formula:
C21H23NO
Molecular Weight:
305.421
Purity:
0.98
SMILES:
CCCCCn1cc(C(=O)Cc2ccccc2)c2ccccc12
References
1. Pekala K, Michalak A, Kruk-Slomka M, Budzynska B, Biala G. Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice. Behav Brain Res. 2018 Mar 15;347:167-174. doi: 10.1016/j.bbr.2018.03.019. [Epub ahead of print] PubMed PMID: 29551733.
2. de la Asunci?n-Nadal V, Armenta S, Garrigues S, de la Guardia M. Identification and determination of synthetic cannabinoids in herbal products by dry film attenuated total reflectance-infrared spectroscopy. Talanta. 2017 May 15;167:344-351. doi: 10.1016/j.talanta.2017.02.026. Epub 2017 Feb 12. PubMed PMID: 28340730.
3. Mascini M, Montesano C, Perez G, Wang J, Compagnone D, Sergi M. Selective solid phase extraction of JWH synthetic cannabinoids by using computationally designed peptides. Talanta. 2017 May 15;167:126-133. doi: 10.1016/j.talanta.2017.01.072. Epub 2017 Jan 29. PubMed PMID: 28340702.
4. Funada M. [Pharmacological properties and dependence liabilities of synthetic cannabinoids]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2010 Jun;45(3):167-74. Review. Japanese. PubMed PMID: 20681249.